EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Evaluating the efficacy of immunochemoradiotherapy in malignant pleural mesothelioma and distinguishing benign from malignant lymph nodes using 18F-FDG PET/CT and 18F-FAPI-04 PET/CT imaging: A case report

Mengye Peng, Menglu Wang, Ying Zhang, Tingting Wu, Kezheng Wang

Advances in Radiotherapy & Nuclear Medicine · 2023

DOI: 10.36922/arnm.0963 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Advances in Radiotherapy & Nuclear Medicine, 2023. Verfasst von Mengye Peng und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this paper, we report a case of pleural mesothelioma, imaged employing 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT), and 18F-fibroblast activating protein inhibitor (FAPI)-04 PET/CT. The diagnosis of pleural mesothelioma was confirmed by histopathologically examining the thoracoscopic biopsy. The patient underwent an 18F-FDG PET/CT before immunochemoradiotherapy, followed by an 18F-FAPI-04 imaging 3 months after treatment. The changes in focal anatomy, morphology, and metabolic biology observed between the two distinct PET/CT imaging modalities can aid in distinguishing benign and malignant lymph nodes and assessing treatment efficacy. This case highlights the diagnostic utility of 18F-FDG PET/C in pleural mesothelioma and suggests that 18F-FAPI-04 PET/CT may serve as an effective tool for evaluating the outcomes of immunochemotherapy. Moreover, the combined application of 18F-FDG PET/CT and 18F-FAPI-04 PET/CT holds promise for the differentiation of benign and malignant lymph nodes.

Zitieren

APA

Peng, M., Wang, M., Zhang, Y., Wu, T., & Wang, K. (2023). Evaluating the efficacy of immunochemoradiotherapy in malignant pleural mesothelioma and distinguishing benign from malignant lymph nodes using 18F-FDG PET/CT and 18F-FAPI-04 PET/CT imaging: A case report. Advances in Radiotherapy & Nuclear Medicine. https://doi.org/10.36922/arnm.0963

Vancouver

Peng M, Wang M, Zhang Y, Wu T, Wang K. Evaluating the efficacy of immunochemoradiotherapy in malignant pleural mesothelioma and distinguishing benign from malignant lymph nodes using 18F-FDG PET/CT and 18F-FAPI-04 PET/CT imaging: A case report. Advances in Radiotherapy & Nuclear Medicine. 2023. doi:10.36922/arnm.0963

BibTeX
@article{Peng2023,
  author = {Peng, Mengye and Wang, Menglu and Zhang, Ying and Wu, Tingting and Wang, Kezheng},
  title = {Evaluating the efficacy of immunochemoradiotherapy in malignant pleural mesothelioma and distinguishing benign from malignant lymph nodes using 18F-FDG PET/CT and 18F-FAPI-04 PET/CT imaging: A case report},
  journal = {Advances in Radiotherapy & Nuclear Medicine},
  year = {2023},
  doi = {10.36922/arnm.0963}
}
Kostenlos starten →